Literature DB >> 13216165

[The significance of factor X for anticoagulant therapy].

P FLUCKIGER, F DUCKERT, F KOLLER.   

Abstract

Keywords:  ANTICOAGULANTS/therapeutic use; BLOOD COAGULATION

Mesh：

Substances：

Year:  1954        PMID： 13216165

Source DB:  PubMed          Journal:  Schweiz Med Wochenschr        ISSN： 0036-7672


× No keyword cloud information.
  6 in total

1.  [ACTIVATION OF BLOOD COAGULATION BY A BACTERIAL ENDOTOXIN IN PERSONS UNDER COUMARIN THERAPY].

Authors:  M H HOERDER; R MANRIQUE
Journal:  Klin Wochenschr       Date:  1965-04-01

Review 2.  [THE STUART-PROWER FACTOR: ITS COAGULATION PHYSIOLOGY AND CLINICAL SIGNIFICANCE].

Authors:  V HIEMEYER; M H HOERDER
Journal:  Klin Wochenschr       Date:  1964-11-15

3.  Biochemical genetics of blood coagulation.

Authors:  J B GRAHAM
Journal:  Am J Hum Genet       Date:  1956-06       Impact factor: 11.025

4.  [Thromboelastographical studies of various disorders of the preliminary and first phases of blood coagulation; a critical note on thromboelastography].

Authors:  F K BELLER; F KOCH; E MAMMEN
Journal:  Blut       Date:  1956-04

5.  [Familial deficiency of factor X].

Authors:  J OEHME; G SCHWICK; H E SCHULTZE
Journal:  Klin Wochenschr       Date:  1958-06-01

6.  [Hemorrhagic disease of the newborn].

Authors:  F KOCH
Journal:  Klin Wochenschr       Date:  1956-02-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.